	US 7,566,702 B2
	Immunostimulatory oligonucleotide multimers
Sudhir Agrawal, Shrewsbury, Mass. (US); Ekambar Kandimalla, Southboro, Mass. (US); and Dong Yu, Westboro, Mass. (US)
Assigned to Idera Pharmaceuticals, Inc., Cambridge, Mass. (US)
Filed on Sep. 22, 2005, as Appl. No. 11/234,075.
Application 11/234075 is a continuation of application No. 10/892550, filed on Jul. 15, 2004.
Application 10/892550 is a continuation of application No. 11/153054, filed on Jun. 15, 2005.
Claims priority of provisional application 60/579985, filed on Jun. 15, 2004.
Claims priority of provisional application 60/559362, filed on Aug. 06, 2004.
Prior Publication US 2006/0094681 A1, May 04, 2006
This patent is subject to a terminal disclaimer.
Int. Cl. C07H 21/02 (2006.01); C07H 21/04 (2006.01); A01N 43/04 (2006.01); A61K 31/70 (2006.01)

U.S. Cl. 514—44 [514/45; 536/23.1]

7 Claims

1. An immunostimulatory oligonucleotide having the structure 5′-CTGTCG₂TTCTCo-X-oCTCTTG₂CTGTC-5′; wherein X is a glycerol linker, o is phosphodiester linkage and G₂is arabinoguanosine.